Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma BiomarkersNiklas Mattsson, Oskar Hansson, Erik Stomrud et al.|JAMA Neurology|2023Cited by 293
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseasePontus Erickson, Prashanthi Vemuri, Joel Simrén et al.|JAMA Neurology|2023Cited by 46